FLT3 Internal Tandem Duplication
1 clinical trials · Condition
◉ Watch FLT3 Internal Tandem Duplication
| Record | Firm | Date |
|---|---|---|
| Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia (NCT03513484) | Northwestern University | 2018-11-14 |
Track FLT3 Internal Tandem Duplication automatically
Every clearance here is in the API, with alerts when new ones post.